Professor Ido Amit from the Immunology Department at the world-renowned Weizmann Institute of Science in Israel will be joining the CELLINK advisory board. Prof. Amit earned his PhD in biologicalnregulation at the Weizmann Institute of Science in 2007. He was a postdoctoral fellow at the BroadnInstitute at Harvard University and the Massachusetts Institute of Technology […]

Amsterdam, the Netherlands —  LUMICKS is proud to announce the opening of its branch office in Beijing, China. As LUMICKS continues to expand within the rapidly developing life sciences and immuno-oncology market in the Asia-Pacific Region (APR), the new office will allow to better serve the market opportunity, support local customers, and collaborate with regional […]

Cytena GmbH and its affiliate cytena Bioprocess Solutions Ltd., part of CELLINK Life Sciences, announced today that they will collaborate with AstraZeneca to develop a new generation of plate-based microbioreactors that can improve the efficiency of cell line development workflows. Cytena, which focuses on developing and commercializing innovative single-cell isolation and cultivation technologies, says that its collaboration with […]

Oslo-Norway and Utrecht-The Netherlands — Bayer AS has installed a state-of-the-art MILabs VECTor PET/SPECT/CT system to support its Targeted Alpha Therapy (TAT) platform of oncology projects. After its success with radium-223 dichloride (Xofigo), the first and only clinically approved targeted alpha therapy, Bayer is advancing an emerging class of novel targeted alpha therapies that combine […]

Clonality assurance assay and genetic stability analysis UTRECHT, THE NETHERLANDS –  Cergentis, a genomics company that develops and commercializes kits and services based on its proprietary Targeted Locus Amplification (TLA) technology, today announced the expansion of its product portfolio with new service packages for cell line development: clonality assurance package and genetic stability package. These […]

New CEO to steer the next stage of Axol Bioscience’s growth in the global iPSC stem cell markets Cambridge, UK: Axol Bioscience, a biotechnology company specializing in the use of stem cell technology to manufacture disease relevant cell based assay systems to the drug discovery industry, today announced the appointment of Liam Taylor as CEO. Liam […]

IsoPlexis partners with Medquest to expand its single-cell proteomic analysis platform, the IsoLight system and IsoCode & CodePlex Chips, throughout the pharmaceutical and life science markets in Malaysia and Singapore BRANFORD, Conn. — IsoPlexis, the leader in single-cell proteomics products, today announced an exclusive agreement with Medquest, a company offering top-tier healthcare solutions to healthcare […]

With his international management experience and extensive network in various life science markets, Thomas Bachmann is a great asset to Cytosurge and will continue to develop its strategic future markets. Zurich | We are pleased to announce Thomas Bachmann as a new member of our Board of Directors. Thanks to his proven and long-standing strategic management experience […]

HAMPTON, N.J. — Visikol originally began a little over four years ago focused entirely on providing researchers with reagents to image tissues in 3D such that they could move beyond traditional 2D histopathology and study tissues intact in their entirety. These products have now been used by over one thousand research labs, and in the last few […]

96-well Air / Liquid Interface (ALI) exposure / For reliable high throughput testing of cell cultures The VITROCELL® Cloud Alpha 96 is our newest innovation and presents a great leap forward in automated exposure of cell cultures. It combines high throughput testing with ease of use. The development is based on the well-known and frequently […]